Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | MSH2 |
| Variant | E226* |
| Impact List | nonsense |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | MSH2 E226* results in a premature truncation of the Msh2 protein at amino acid 226 of 934 (UniProt.org). E226* has not been characterized however, due to the loss of the ATPase domain (PMID: 17531815, PMID: 23391514), is predicted to lead to a loss of Msh2 protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
MSH2 mutant MSH2 inact mut MSH2 E226* |
| Transcript | NM_000251.3 |
| gDNA | chr2:g.47412444G>T |
| cDNA | c.676G>T |
| Protein | p.E226* |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_001406649.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| NM_001406657.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| NM_001406639.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| NM_001406641.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| NM_001406635.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| NM_001406636.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| NM_001406633.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| NM_001406632.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| NM_001406652.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| NM_001406651.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| NM_001406640.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| NM_001406645.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| NM_001406631.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| XM_047444416.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| NM_001406638.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| NM_001406672.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| NM_001406647.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| NM_001406674.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| NM_001406655.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| NM_001406634.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| NM_001406650.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| NM_001406643.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| NM_001406637.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| NM_001406648.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| NM_001406642.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| NM_000251.3 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| NM_001406646.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| NM_001406666.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| NM_001406644.1 | chr2:g.47412444G>T | c.676G>T | p.E226* | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|